Tanriverdi, L. H. Et Al. 2022. Activation of the Mas receptors by AVE0991 and MrgD receptor using Alamandine to limit the deleterious effects of Ang II‐induced hypertension. FUNDAMENTAL AND CLINICAL PHARMACOLOGY , vol.1, no. 1 , 1-15.

Tanriverdi, L. H., Özhan, O., Ulu, A., Yildiz, A., Ateş, B., Vardi, N., ... Acet, H. A.(2022). Activation of the Mas receptors by AVE0991 and MrgD receptor using Alamandine to limit the deleterious effects of Ang II‐induced hypertension. FUNDAMENTAL AND CLINICAL PHARMACOLOGY , vol.1, no. 1, 1-15.

Tanriverdi, LOKMAN Et Al. "Activation of the Mas receptors by AVE0991 and MrgD receptor using Alamandine to limit the deleterious effects of Ang II‐induced hypertension," FUNDAMENTAL AND CLINICAL PHARMACOLOGY , vol.1, no. 1, 1-15, 2022

Tanriverdi, LOKMAN H. Et Al. "Activation of the Mas receptors by AVE0991 and MrgD receptor using Alamandine to limit the deleterious effects of Ang II‐induced hypertension." FUNDAMENTAL AND CLINICAL PHARMACOLOGY , vol.1, no. 1, pp.1-15, 2022

Tanriverdi, L. H. Et Al. (2022) . "Activation of the Mas receptors by AVE0991 and MrgD receptor using Alamandine to limit the deleterious effects of Ang II‐induced hypertension." FUNDAMENTAL AND CLINICAL PHARMACOLOGY , vol.1, no. 1, pp.1-15.

@article{article, author={LOKMAN HEKİM TANRIVERDİ Et Al. }, title={Activation of the Mas receptors by AVE0991 and MrgD receptor using Alamandine to limit the deleterious effects of Ang II‐induced hypertension}, journal={FUNDAMENTAL AND CLINICAL PHARMACOLOGY}, year=2022, pages={1-15} }